|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：D416817 |
| 產(chǎn)品名稱：5,6-Diamino-2-thiouracil-13C,15N |
| 產(chǎn)品CAS：1246816-80-7 |
| 規(guī)格含量：100mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
D416817 |
| 名稱: |
5,6-Diamino-2-thiouracil-13C,15N |
| 別名: |
5,6-Diamino-2,3-dihydro-2-thioxo-4(1H)-pyrimidinone-13C,15N; 5,6-Diamino-2-thio-uracil;-13C,15N 2-Mercapto-4,5-diamino-6-hydroxypyrimidine-13C,15N; 4,5-Diamino-2-mercaptopyrimidin-6-ol-13C,15N; 4,5-Diamino-6-hydroxy-2-mercaptopyrimidine-13C,15N; 5,6-Diamino-2-thiouracil-13C,15N; NSC 147804-13C,15N; NSC 45759-13C,15N; |
| CAS號(hào): |
1246816-80-7 |
| 參考CAS號(hào): |
類似: 1004-76-8 |
| 分子式: |
C?¹³CH?N?¹?NOS |
| 外觀: |
淡黃色固體 |
| 分子量: |
160.17 |
| 溶解性: |
Aqueous Sodium Hydroxide |
| 種類: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Key intermediate in the production of anticancer and analgesic agents. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
